Copyright
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 107722
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107722
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107722
Table 1 Current decolonization therapies in pediatric surgical disorders
| Therapy | Description | Advantages | Pediatric surgical disorders | Ref. |
| Selective digestive decontamination | Administration of non-absorbable antibiotics to reduce harmful bacteria load in the gut before surgery | Prevents postoperative infections; Reduces translocation of harmful pathogens | IBD; SBS | [98,159] |
| Probiotics | Combination pf beneficial bacteria and nutrients that promote their growth | Enhance colonization resistance; Reduces MDR bacteria like Acinetobacter baumannii | IBD; NEC; HAEC; SBS | [105,119-122,139,155] |
| FMT | Transfer of fecal material from a healthy donor to restore fecal balance | Restores microbial diversity; Suppresses MDR bacteria. Effective for Clostridium dif. infections | IBD; NEC; SBS | [112,126,156,157] |
- Citation: Vaou N, Zavras N, Fessatou S, Voidarou CC, Vrioni G, Tsakris A, Vaos G. Microbiota decolonization of bacterial pathogens in pediatric surgery-related intestinal disorders: Insights on current strategies and future outlook. World J Clin Pediatr 2025; 14(4): 107722
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/107722.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.107722
